2015
Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease
Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, Mena-Hurtado C, Metzger DC, Brodmann M, Pilger E, Zeller T, Krishnan P, Gammon R, Müller-Hülsbeck S, Nehler MR, Benenati JF, Scheinert D. Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. New England Journal Of Medicine 2015, 373: 145-153. PMID: 26106946, DOI: 10.1056/nejmoa1406235.Peer-Reviewed Original ResearchConceptsDrug-coated balloonsPaclitaxel-coated balloonPeripheral artery diseasePercutaneous transluminal angioplastyPrimary patencyArtery diseaseTransluminal angioplastyStandard angioplastyStandard balloonSymptomatic femoropopliteal peripheral artery diseaseFemoropopliteal peripheral artery diseasePrimary efficacy end pointPrimary safety end pointEnd pointSignificant between-group differencesComposite of freedomPrimary safety eventsSymptomatic intermittent claudicationEfficacy end pointSafety end pointFemoropopliteal artery diseaseProportion of patientsSignificant atherosclerotic lesionsBetween-group differencesRate of death
1988
Preservation of left ventricular ejection fraction during percutaneous transluminal coronary angioplasty by distal transcatheter coronary perfusion of oxygenated fluosol DA 20%
Jaffe C, Wohlgelernter D, Cabin H, Bowman L, Deckelbaum L, Remetz M, Cleman M. Preservation of left ventricular ejection fraction during percutaneous transluminal coronary angioplasty by distal transcatheter coronary perfusion of oxygenated fluosol DA 20%. American Heart Journal 1988, 115: 1156-1164. PMID: 2967624, DOI: 10.1016/0002-8703(88)90002-6.Peer-Reviewed Original ResearchConceptsVentricular ejection fractionPercutaneous transluminal coronary angioplastyTransluminal coronary angioplastyEjection fractionCoronary perfusionBalloon inflationCoronary angioplastyDistal coronary perfusionLeft ventricular functionDistal coronary arteriesEnd-diastolic volumeEnd-systolic volumeTwo-dimensional echocardiographyFluosol-DA 20Area-length methodOxygenated perfluorocarbon emulsionPercutaneous Transluminal Coronary Angioplasty During Acute Myocardial Infarction
Remetz M, Cleman M. Percutaneous Transluminal Coronary Angioplasty During Acute Myocardial Infarction. Cardiology Clinics 1988, 6: 139-152. PMID: 2971441, DOI: 10.1016/s0733-8651(18)30507-1.Peer-Reviewed Original ResearchMeSH KeywordsAngioplasty, BalloonClinical Trials as TopicCombined Modality TherapyCoronary CirculationFibrinolytic AgentsHumansMyocardial InfarctionConceptsSystemic thrombolytic therapyThrombolytic therapyVentricular functionAcute MISymptom onsetAcute PTCABlood flowPercutaneous transluminal coronary angioplastyInitial thrombolytic therapyRecent cerebrovascular eventsIntravenous thrombolytic therapyCent of patientsInfarct-related arteryPost-infarction anginaRegional left ventricular functionImproved ventricular functionTransluminal coronary angioplastyLeft ventricular functionAcute myocardial infarctionIntravenous r-tPASecond generation thrombolytic agentUse of PTCAAcute angioplastyIntracoronary streptokinaseProvokable ischemia